The Structural Engineering of Modern Sushi The international landscape for Japanese cuisine is defined by a shift toward ...
China's sports medicine market grows fast with policy support and rising demand, creating major opportunities for foreign ...
New research highlights how biogenic materials, ranging from antimicrobial nanoparticles to biomorphic bone scaffolds, are ...
In the second of a two-part examination of modern Ukrainian ideas and identities, Canadian scholar Bohdan Krawchenko ...
The Federal Government commissions a ₦40 billion CCTV Control Centre for Third Mainland Bridge as Nigerians debate cost, ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (CYTK) today announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten), 5 ...
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company’s First ...
The study was performed on a preliminary trial including 24 neonates at postmenstrual age equivalent to those of late preterm infants. To confirm the relevance of the results, the sample size has been ...
Company to Host Investor Conference Call Today at 4:30 PM Eastern Time SOUTH SAN FRANCISCO, Calif., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback